Class IITerminatedD-1496-2022
Drug recall · September 14, 2022
Sodium Chloride Ophthalmic Ointment USP recall
Why: cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35
- Lots / codes
Lot#: 9J58A, 9J58B, Exp 8/31/2022
- Quantity
- 48,636 tubes
- Company
- Akorn, Inc., Gurnee, IL
- Distribution
- USA nationwide
- Initiated
- August 31, 2022 · Voluntary: Firm initiated
- Classified
- September 6, 2022
- Reported
- September 14, 2022
- Ended
- June 18, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.